These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34274186)

  • 1. Symmetrical intertriginous and flexural exanthema related to the use of paracetamol.
    Dias JAF; Campos LM; Schmitt JV; Marques SA
    An Bras Dermatol; 2021; 96(5):646-647. PubMed ID: 34274186
    [No Abstract]   [Full Text] [Related]  

  • 2. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
    Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
    [No Abstract]   [Full Text] [Related]  

  • 3. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetrical drug-related intertriginous and flexural exanthema due to codeine.
    Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M
    Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105
    [No Abstract]   [Full Text] [Related]  

  • 6. SDRIFE (baboon syndrome) due to paracetamol: case report.
    Lugović-Mihić L; Duvančić T; Vučić M; Situm M; Kolić M; Mihić J
    Acta Dermatovenerol Croat; 2013; 21(2):113-7. PubMed ID: 24001419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
    Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
    Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
    [No Abstract]   [Full Text] [Related]  

  • 8. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
    Moreira C; Cruz MJ; Cunha AP; Azevedo F
    An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
    [No Abstract]   [Full Text] [Related]  

  • 9. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema.
    Choi MJ; Oh SH; Cho SB
    Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789
    [No Abstract]   [Full Text] [Related]  

  • 11. Fixed exanthema due to paracetamol.
    Gómez Martínez M; Fernández de Miguel C; Domínguez Lázaro A; Laguna Martínez JJ; Orta Martiartu M; Lozano Ayllón M
    J Investig Allergol Clin Immunol; 1996; 6(2):131-2. PubMed ID: 8727272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of symmetrical drug-related intertriginous and flexural exanthema induced by acetaminophen.
    Obara K; Maejima H; Katayama C; Takasu H; Amoh Y
    J Dermatol; 2014 Dec; 41(12):1132-3. PubMed ID: 25385002
    [No Abstract]   [Full Text] [Related]  

  • 13. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
    Lim PN; Wylie G
    Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported cases.
    Rao A; Francis N; Morar N
    Br J Dermatol; 2012 May; 166(5):1142-3. PubMed ID: 22121994
    [No Abstract]   [Full Text] [Related]  

  • 16. Symmetrical drug-related intertriginous and flexural exanthema induced by metronidazole suppository.
    Zhang H; Xie Z
    Contact Dermatitis; 2021 Jun; 84(6):486-488. PubMed ID: 33421140
    [No Abstract]   [Full Text] [Related]  

  • 17. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema.
    Kim EY; Awh KC; Larocca CA
    Acta Derm Venereol; 2023 Dec; 103():adv12197. PubMed ID: 38112207
    [No Abstract]   [Full Text] [Related]  

  • 18. Itraconazole-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a rare occurrence.
    Kalita BJ; Das S; Dutta B
    Int J Dermatol; 2020 Nov; 59(11):e419-e421. PubMed ID: 32767394
    [No Abstract]   [Full Text] [Related]  

  • 19. A rare case of symmetrical drug-related intertriginous and flexural exanthema due to pantoprazole.
    Kothari R; Pal R; Bhatnagar A; Kishore K; Patil C
    Int J Dermatol; 2022 Sep; 61(9):e330-e331. PubMed ID: 35235207
    [No Abstract]   [Full Text] [Related]  

  • 20. Zoledronic acid-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
    Kandala H; Gonzalez-Mosquera LF; Barua P; Podrumar A
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34518192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.